Fabrizio Carta

About Fabrizio Carta

Fabrizio Carta, With an exceptional h-index of 59 and a recent h-index of 45 (since 2020), a distinguished researcher at Università degli Studi di Firenze, specializes in the field of Medicinal Chemistry, Drug Design.

His recent articles reflect a diverse array of research interests and contributions to the field:

2-Substituted-4, 7-dihydro-4-ethylpyrazolo [1, 5-a] pyrimidin-7-ones alleviate LPS-induced inflammation by modulating cell metabolism via CD73 upon macrophage polarization

Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy

Origanum majorana L. polyphenols: in vivo antiepileptic effect, in silico evaluation of their bioavailability, and interaction with the NMDA receptor

Benzenesulfonamide decorated dihydropyrimidin (thi) ones: carbonic anhydrase profiling and antiproliferative activity

Carbonic anhydrase, its inhibitors and vascular function

Integrase

Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates

Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships

Fabrizio Carta Information

University

Position

-Dept. Neurofarba

Citations(all)

12007

Citations(since 2020)

6768

Cited By

8111

hIndex(all)

59

hIndex(since 2020)

45

i10Index(all)

190

i10Index(since 2020)

164

Email

University Profile Page

Google Scholar

Fabrizio Carta Skills & Research Interests

Medicinal Chemistry

Drug Design

Top articles of Fabrizio Carta

2-Substituted-4, 7-dihydro-4-ethylpyrazolo [1, 5-a] pyrimidin-7-ones alleviate LPS-induced inflammation by modulating cell metabolism via CD73 upon macrophage polarization

Molecular Immunology

2024/6/1

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy

Journal of Medicinal Chemistry

2024/1/24

Andrea Angeli
Andrea Angeli

H-Index: 25

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Origanum majorana L. polyphenols: in vivo antiepileptic effect, in silico evaluation of their bioavailability, and interaction with the NMDA receptor

Frontiers in Chemistry

2024/1/19

Imane Es-Safi
Imane Es-Safi

H-Index: 4

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Benzenesulfonamide decorated dihydropyrimidin (thi) ones: carbonic anhydrase profiling and antiproliferative activity

RSC Medicinal Chemistry

2024

Carbonic anhydrase, its inhibitors and vascular function

2024

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Integrase

2024/1/1

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates

Journal of Enzyme Inhibition and Medicinal Chemistry

2023/12/31

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Alessio Nocentini
Alessio Nocentini

H-Index: 28

Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships

Journal of Enzyme Inhibition and Medicinal Chemistry

2023/12/31

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Andrea Angeli
Andrea Angeli

H-Index: 25

Selected strategies to fight pathogenic bacteria

2023/12/31

Novel Drug Screening Assay for Acanthamoeba castellanii and the Anti-Amoebic Effect of Carbonic Anhydrase Inhibitors

Journal of medicinal chemistry

2023/12/27

Fabrizio Carta
Fabrizio Carta

H-Index: 41

A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration

Antioxidants

2023/11/25

Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia

European Journal of Medicinal Chemistry

2023/11/15

Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action

ChemMedChem

2023/11/2

Andrea Angeli
Andrea Angeli

H-Index: 25

Fabrizio Carta
Fabrizio Carta

H-Index: 41

State of the art of carbonic anhydrase activators

2023/11

Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition

Future Medicinal Chemistry

2023/10

Fabrizio Carta
Fabrizio Carta

H-Index: 41

The integrase: an overview of a key player enzyme in the antiviral scenario

2023/7/29

Fabrizio Carta
Fabrizio Carta

H-Index: 41

First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome

Journal of Medicinal Chemistry

2023/7/12

Escinosome thermosensitive gel optimizes efficacy of CAI-CORM in a rat model of rheumatoid arthritis

Journal of Ophthalmology Clinics and Research

2023/6/1

Uncovering novel capsaicin inhibitory activity towards human carbonic anhydrase isoforms IX and XII by combining in silico and in vitro studies

Antioxidants

2023/5/18

Fabrizio Carta
Fabrizio Carta

H-Index: 41

Membrane permeability is required for the vasodilatory effect of carbonic anhydrase inhibitors in porcine retinal arteries

International Journal of Molecular Sciences

2023/5/2

Daniela Vullo
Daniela Vullo

H-Index: 44

Fabrizio Carta
Fabrizio Carta

H-Index: 41

See List of Professors in Fabrizio Carta University(Università degli Studi di Firenze)

Co-Authors

academic-engine